Loading clinical trials...
Loading clinical trials...
β-glucan Rich Barley and Rice Mixes and Post-prandial Glycemia - a Dose Response Study
The purpose of this research was to investigate 5 different formulations of whole grain barley and refined white rice against a control of white bread on post-prandial glycemic response, as well as self-reported hunger/satiety in a randomized cross-over trial.
Beta-glucan-rich barley has been shown to improve glycemic response, reduce hunger and increase satiety. Nutrient-dense grain mixtures that include a new cultivar of barley (Sustagrain, Ardent Mills, LLC) with exceptionally high dietary fiber content may help individuals meet their dietary fiber needs while minimizing the rapid increase in blood glucose following the consumption of a refined grain product. The primary objective of this study was to compare the effects of five different test meals containing varying amounts of whole-grain barley and refined white rice to white bread on post-prandial blood glucose concentrations. A secondary aim was to evaluate changes in self-reported hunger and satiety following the consumption of each treatment. This study was a single-site, blinded, randomized crossover trial among 24 healthy adults. Each participant consumed the following treatments: 100% Sustagrain barley flakes, 100% Sustagrain steel cut barley , an 80/20 rice-steel cut Sustagrain barley mix, a 50/50 rice-steel cut Sustagrain barley mix, 100% rice, and white bread.
Age
18 - 50 years
Sex
ALL
Healthy Volunteers
Yes
Arizona Biomedical Collaborative
Phoenix, Arizona, United States
Start Date
February 13, 2017
Primary Completion Date
September 4, 2017
Completion Date
September 18, 2017
Last Updated
January 2, 2018
39
ACTUAL participants
100% steel cut barley
OTHER
100% barley flakes
OTHER
50/50 rice-barley mix
OTHER
80/20 rice-barley mix
OTHER
100% rice
OTHER
white bread
OTHER
Lead Sponsor
Arizona State University
Collaborators
NCT07043478
NCT07256652
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06973408